(veliparib/BRCA) AbbVie’s phase 2 PARP study misses survival endpoints; hopes rest on bigger phase 3 Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, December 07, 2016

(veliparib/BRCA) AbbVie’s phase 2 PARP study misses survival endpoints; hopes rest on bigger phase 3



pharma news

0 comments :

Post a Comment

Your comments?